Since TGF-β, Smad2, and α-SMA are positively related to the activation of TGF-β signaling, our findings illustrate that the silencing of lncRNA EZR-AS1 blocks TGF-β signaling in CRC cells. The gene discussed is SMAD2; the disease is colorectal carcinoma.